Medical

biclonality

bi·clon·al·i·ty

(bī'klōn-al'i-tē),
A condition in which some cells have markers of one cell line and other cells have markers of another cell line, as in biclonal leukemias.
Farlex Partner Medical Dictionary © Farlex 2012

biclonality

The uncommon occurrence of an uncontrolled expansion of 2 or more clones of neoplastic cells, as in the biclonal expansion of 2 B-cell lines or B- and T-cell lines. Biclonality contrasts to the more common uncontrolled clonal expansion of a single, often hematopoietic progenitor cell line
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.

biclonality

The rare occurrence of an uncontrolled expansion of 2–or more clones of neoplastic cells, as in the biclonal expansion of 2 B cell lines or B and T cell lines. Cf Composite lymphoma.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.

bi·clon·al·i·ty

(bī-klōn-al'i-tē)
A condition in which some cells have markers of one cell line and other cells have markers of another cell line, as in biclonal leukemias.
Medical Dictionary for the Health Professions and Nursing © Farlex 2012
Mentioned in
References in periodicals archive
Biclonality of composite B- and T-cell lymphomas: a case report.
Primary Cutaneous Composite Lymphomas
On the other hand, in the case of CLL and plasma cell neoplasm coincidence, a recent detailed molecular evaluation comparing the cytogenetic aberrations of these 2 malignancies in 5 patients found all evaluable cases to express features consistent with biclonality [14].
One patient, two uncommon B-cell neoplasms: solitary plasmacytoma following complete remission from intravascular large B-cell lymphoma involving central nervous system
Oligoclonality and biclonality shows a skewed spectratype profile with a single dominant peak and double peaks, respectively.
The feature of distribution and clonality of TCR [gamma]/[delta] subfamilies T cells in patients with B-cell non-Hodgkin lymphoma
One report has described chromosome 7 biclonality in four uterine leiomyomas (Ozisik et al.
Etiology and pathogenesis of uterine leiomyomas: a review. (Research Review)
In one case (10%), positivity with 1 of those 2 primer sets was the only molecular evidence of biclonality; 2 clonal populations were identified with IGH FR1 and IGH FR3 primer sets in 4 cases (40%; 2 [20%] with IGH FR1 and 2 [20%] with IGH FR3), and 2 of these cases (the ones with biclonal results for IGH FR1) also demonstrated biclonal populations with the IGH FR2 primer set.
The utility of the BIOMED-2 primers in the detection of 2 clonal, B-lymphoproliferative disorders simultaneously involving the same site
Copyright © 2003-2025 Farlex, Inc Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.